ES2040217T3 - Procedimiento para preparar derivados de acido flavona-carboxilico. - Google Patents

Procedimiento para preparar derivados de acido flavona-carboxilico.

Info

Publication number
ES2040217T3
ES2040217T3 ES198787103691T ES87103691T ES2040217T3 ES 2040217 T3 ES2040217 T3 ES 2040217T3 ES 198787103691 T ES198787103691 T ES 198787103691T ES 87103691 T ES87103691 T ES 87103691T ES 2040217 T3 ES2040217 T3 ES 2040217T3
Authority
ES
Spain
Prior art keywords
lower alkyl
hydrogen
iii
formula
flavona
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787103691T
Other languages
English (en)
Spanish (es)
Inventor
Koichi Prof. Shudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of ES2040217T3 publication Critical patent/ES2040217T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES198787103691T 1986-03-18 1987-03-14 Procedimiento para preparar derivados de acido flavona-carboxilico. Expired - Lifetime ES2040217T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61059850A JPS62215581A (ja) 1986-03-18 1986-03-18 フラボンカルボン酸誘導体

Publications (1)

Publication Number Publication Date
ES2040217T3 true ES2040217T3 (es) 1993-10-16

Family

ID=13125083

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787103691T Expired - Lifetime ES2040217T3 (es) 1986-03-18 1987-03-14 Procedimiento para preparar derivados de acido flavona-carboxilico.

Country Status (7)

Country Link
US (2) US4831052A (en:Method)
EP (1) EP0237986B1 (en:Method)
JP (1) JPS62215581A (en:Method)
AT (1) ATE67995T1 (en:Method)
DE (1) DE3773415D1 (en:Method)
ES (1) ES2040217T3 (en:Method)
GR (1) GR3002832T3 (en:Method)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0374789A1 (en) * 1988-12-19 1990-06-27 Kyowa Hakko Kogyo Co., Ltd. 5- Aminoflavone derivatives
DE3903992A1 (de) * 1989-02-10 1990-08-16 Basf Ag Aromatische ketoverbindungen, ihre herstellung und arzneimittel sowie kosmetika daraus
US5194664A (en) * 1989-02-10 1993-03-16 Basf Aktiengesellschaft Aromatic keto compounds, the preparation thereof, and drugs and cosmetics containing these
FR2661410B1 (fr) * 1990-04-27 1994-06-03 Caignard Daniel Nouveaux derives heterocycliques: 2-styryl 4h-1-benzopyrane-4-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DK0617614T3 (da) * 1991-12-18 1998-09-28 Salk Inst For Biological Studi Midler til modulering af processer medieret af retinoide receptorer og forbindelser anvendlige dertil
EP0619116A3 (en) * 1993-04-05 1994-11-23 Hoechst Japan Use of synthetic retinoids for osteopathy.
US5770378A (en) * 1994-12-30 1998-06-23 Ligand Pharmaceuticals, Inc. Tricyclic retinoids, methods for their production and use
US5770382A (en) * 1994-12-30 1998-06-23 Ligand Pharmaceuticals, Inc. Tricyclic retinoids, methods for their production and use
US5770383A (en) * 1994-12-30 1998-06-23 Ligand Pharmaceuticals, Inc. Tricyclic retinoids, methods for their production and use
WO1997012853A1 (en) 1995-10-06 1997-04-10 Ligand Pharmaceuticals Incorporated Dimer-selective rxr modulators and methods for their use
CA2334545A1 (en) 1998-06-12 1999-12-16 Ligand Pharmaceuticals Incorporated Treatment of anti-estrogen resistant breast cancer using rxr modulators
DE19918365A1 (de) * 1999-04-22 2000-10-26 Stefan Martens Genetische Sequenz, die für Flavonsynthase II Enzyme kodiert, und deren Verwendung
CA2378298A1 (en) 1999-08-27 2001-03-08 Lawrence G. Hamann 8-substituted-6-trifluoromethyl-9-pyrido¬3,2-g|quinoline compounds as androgen receptor modulators
CN1391576A (zh) 1999-08-27 2003-01-15 利甘德药品公司 雄激素受体调节剂化合物及方法
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
JP2003529545A (ja) * 1999-09-14 2003-10-07 リガンド・ファーマシューティカルズ・インコーポレイテッド 改善された薬理学的プロファイルを有するｒｘｒモジュレーター
FR2815033B1 (fr) 2000-10-06 2003-09-05 Negma Lab Derives de 7-carboxy-flavones, porcede pour leur preparation et leur application en therapeutique
US9050310B2 (en) * 2004-06-25 2015-06-09 Minas Theodore Coroneo Treatment of ocular lesions
US20060204474A1 (en) * 2005-02-25 2006-09-14 Coroneo Minas T Treatment of epithelial layer lesions
GB0915196D0 (en) 2009-09-01 2009-10-07 King S College London Therapeutic compounds and their use
US11045441B2 (en) 2015-10-13 2021-06-29 Wisconsin Alumni Research Foundation Use of retinoic acid and analogs thereof to treat central neural apneas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1042192A (en) * 1962-07-10 1966-09-14 Benger Lab Ltd Furochromone compounds
GB1461777A (en) * 1973-06-08 1977-01-19 Fisons Ltd 2-phenyl-4-oxo-4h-1-benzopyran derivatives
LU69423A1 (en:Method) * 1974-02-19 1975-12-09
FR2516922A1 (fr) * 1981-11-25 1983-05-27 Lipha Acides (oxo-4-4h-(1)-benzopyran-8-yl) alcanoiques, sels et derives, preparation et medicament les contenant
FR2543140B1 (fr) * 1983-03-24 1985-06-21 Cortial Nouveaux acides flavone-carboxyliques-4', leur methode de preparation et leur application en therapeutique
JPS6122046A (ja) * 1984-07-07 1986-01-30 Koichi Shiyudo スチルベン誘導体
DE3580134D1 (de) * 1984-07-07 1990-11-22 Shudo Koichi Prof Dr Chem Benzoesaeurederivate.

Also Published As

Publication number Publication date
JPH0255430B2 (en:Method) 1990-11-27
EP0237986B1 (en) 1991-10-02
DE3773415D1 (de) 1991-11-07
ATE67995T1 (de) 1991-10-15
EP0237986A3 (en) 1988-10-05
US4831052A (en) 1989-05-16
US4925979A (en) 1990-05-15
EP0237986A2 (en) 1987-09-23
GR3002832T3 (en) 1993-01-25
JPS62215581A (ja) 1987-09-22

Similar Documents

Publication Publication Date Title
ES2040217T3 (es) Procedimiento para preparar derivados de acido flavona-carboxilico.
ES2140391T3 (es) Derivados de dialcoxi-piridinil-bencimidazol, procedimiento para su preparacion y su uso farmaceutico.
ES2108375T3 (es) Derivados de oxazolidinadiona, su produccion y utilizacion para reducir los niveles de azucares y lipidos en sangre.
AR245718A1 (es) Procedimiento para preparar un compuesto de imidazo (4,5-b)-piridina
ES2028857T3 (es) Procedimiento para la preparacion de derivados de amino-tiazol y amino-oxazol.
ES2077066T3 (es) Derivados de 4-aminofenol anti-inflamatorio.
DK0393493T3 (da) Fluorerede galdesyrederivater, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem
ATE107875T1 (de) Wässrige polyurethan dispersionen.
TW333527B (en) Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
ES2117281T3 (es) Nuevos analogos de la vitamina d.
ES2087854T3 (es) Nuevos oxatiolanos y derivados de los mismos, composiciones farmaceuticas que los contienen y el uso de los mismos como medicamentos.
SE8304006D0 (sv) Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
ES2140765T3 (es) Guanididas sustituidas del acido cinamico, procedimiento para su preparacion, su uso como medicamento o agente de diagnostico cardiovascular, asi como medicamento que las contiene.
AR240815A2 (es) Procedimiento para preparar derivados de los acidos benzofuran-5-il y benzotiofen-5-il acetico y propionico
DE3775666D1 (de) Hydroxybutenolid-derivate, ihre herstellung und ihre verwendung.
ES2180100T3 (es) Agentes antitumorales de tioxantenona.
ES8609302A1 (es) Un procedimiento para la preparacion de 4-amino-2-fenilqui- nolinas
ES2090374T3 (es) Derivados de tiazolina, procesos para su preparacion y composiciones plaguicidas que los contienen.
ES2145480T3 (es) Amidas de acido carbamoilcarboxilico.
AR001995A1 (es) Derivados de bencisoxazol, procedimientos para su manufactura, agentes antiparasitarios que los contienen como ingredientes activos y procedimientospara el control de microorganismos fitopatogenicos, insectos y acaros.
ES8600224A1 (es) Procedimiento de preparacion de nuevos derivados carbamiloxibenzoles
ES8704460A1 (es) Un procedimiento para preparar derivados de 2-piridin-tiol
ES8608492A1 (es) Procedimiento para la obtencion de derivados de 3-(ureidociclohexilamino) propan-1, 2-diol
MY103631A (en) Certain insecticidal 6-(phenoxy-2-pyridyl)-methyl-neo-phental ethers
HUT38607A (en) Process for producing phenyl-ethyl-amino-propiophenone derivatives and pharmaceutical composition containing them as active agents

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 237986

Country of ref document: ES